Dissection of the Inflammatory Bowel Disease Transcriptome Using Genome-Wide cDNA Microarrays

Christine Costello(University of Lübeck), Nancy Mah(University of Lübeck), Robert Häsler(University of Lübeck), Philip Rosenstiel(Kiel University), Georg H. Waetzig(Conaris), Andreas Hahn(Max Planck Institute for Informatics), Tim Lu(University of Lübeck), Yeşim Gürbüz(University of Lübeck), Susanna Nikolaus(University of Lübeck), Mario Albrecht(Max Planck Institute for Informatics), Jochen Hampe(University of Lübeck), Ralph Lucius(University Hospital Schleswig-Holstein), G. Klöppel(University Hospital Schleswig-Holstein), Holger Eickhoff(Max Planck Society), Hans Lehrach(Max Planck Institute for Molecular Genetics), Thomas Lengauer(Max Planck Institute for Informatics), Stefan Schreiber(University Hospital Schleswig-Holstein)
PLoS Medicine
August 18, 2005
Cited by 231Open Access
Full Text

Abstract

BACKGROUND: The differential pathophysiologic mechanisms that trigger and maintain the two forms of inflammatory bowel disease (IBD), Crohn disease (CD), and ulcerative colitis (UC) are only partially understood. cDNA microarrays can be used to decipher gene regulation events at a genome-wide level and to identify novel unknown genes that might be involved in perpetuating inflammatory disease progression. METHODS AND FINDINGS: High-density cDNA microarrays representing 33,792 UniGene clusters were prepared. Biopsies were taken from the sigmoid colon of normal controls (n = 11), CD patients (n = 10) and UC patients (n = 10). 33P-radiolabeled cDNA from purified poly(A)+ RNA extracted from biopsies (unpooled) was hybridized to the arrays. We identified 500 and 272 transcripts differentially regulated in CD and UC, respectively. Interesting hits were independently verified by real-time PCR in a second sample of 100 individuals, and immunohistochemistry was used for exemplary localization. The main findings point to novel molecules important in abnormal immune regulation and the highly disturbed cell biology of colonic epithelial cells in IBD pathogenesis, e.g., CYLD (cylindromatosis, turban tumor syndrome) and CDH11 (cadherin 11, type 2). By the nature of the array setup, many of the genes identified were to our knowledge previously uncharacterized, and prediction of the putative function of a subsection of these genes indicate that some could be involved in early events in disease pathophysiology. CONCLUSION: A comprehensive set of candidate genes not previously associated with IBD was revealed, which underlines the polygenic and complex nature of the disease. It points out substantial differences in pathophysiology between CD and UC. The multiple unknown genes identified may stimulate new research in the fields of barrier mechanisms and cell signalling in the context of IBD, and ultimately new therapeutic approaches.


Related Papers

No related papers found

Powered by citation graph analysis